RobertTWechslerMD, PhD, FAES, FAAN

Clinical Trials

• Trial to Demonstrate the Efficacy and Safety of Conversion to Lacosamide Monotherapy for Partial-onset Seizures Start of enrollment: 2007 Aug 01

  Completed

  Phase 3

• Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures Start of enrollment: 2008 Feb 01

  Completed

  Phase 3

• To Evaluate The Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Start of enrollment: 2008 May 01

  Completed

  Phase 3

• Evaluation of the Efficacy and Safety of E2007 (Perampanel) Given as Adjunctive Therapy in Subjects With Refractory Partial Seizures Start of enrollment: 2008 Oct 01

  Completed

  Phase 3

• An Open-label, Multinational, Multicenter, Follow-up Study to Evaluate the Long-term Safety and Efficacy of Brivaracetam Start of enrollment: 2008 Nov 01

  Completed

  Phase 3

• Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs Start of enrollment: 2009 Apr 01

  Completed

  Phase 3

• Eslicarbazepine Acetate Monotherapy Long Term Study Start of enrollment: 2009 Aug 01

  Completed

  Phase 3

• Efficacy and Safety of Eslicarbazepine Acetate (BIA 2-093) as Adjunctive Therapy for Refractory Partial Seizures Start of enrollment: 2008 Dec 02

  Completed

  Phase 3

• Open-Label Study to Assess Lacosamide Safety as Add-on Therapy for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy Start of enrollment: 2010 May 01

  Completed

  Phase 2

• Brivaracetam Efficacy and Safety Study in Subjects With Partial Onset Seizures Start of enrollment: 2010 Dec 01

  Completed

  Phase 3

• A Study of the Structure and Function of the Retina in Adult Patients With Refractory Complex Partial Seizures Treated With Vigabatrin (Sabril®) Start of enrollment: 2010 Dec 01

  Completed

  Phase 4

• Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy Start of enrollment: 2011 May 11

  Completed

  Phase 3

• Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters Start of enrollment: 2011 Jun 01

  Terminated

  Phase 3

• A Efficacy and Safety Study of Adjunctive Perampanel in Primary Generalized Tonic Clonic Seizures Start of enrollment: 2011 Sep 01

  Completed

  Phase 3

• A Study to Evaluate the Efficacy and Safety of VX-765 in Subjects With Treatment-Resistant Partial Epilepsy Start of enrollment: 2011 Dec 01

  Terminated

  Phase 2

• Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters Start of enrollment: 2012 Jul 01

  Terminated

  Phase 3

• A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Start of enrollment: 2013 Jul 31

  Completed

  Phase 2

• An Extended Access Program for Perampanel

  No longer available

• Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension Start of enrollment: 2013 Oct 01

  Completed

  Phase 3

• Efficacy and Safety of GWP42003-P for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults Start of enrollment: 2015 Jun 08

  Completed

  Phase 3

• An Open Label Extension Study of Cannabidiol (GWP42003-P) in Children and Adults With Dravet or Lennox-Gastaut Syndromes Start of enrollment: 2015 Jun 11

  Completed

  Phase 3

• An Extended Access Program (EAP) for Perampanel

  Available

• Staccato Alprazolam and Photoparoxysmal Response Start of enrollment: 2015 Jan 01

  Completed

  Phase 2

• A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications Start of enrollment: 2015 Apr 01

  Completed

  Phase 3

• Safety and Pharmacokinetic Study of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures Start of enrollment: 2016 Aug 03

  Completed

  Phase 3

• Cannabidiol for Pediatric Epilepsy (Compassionate Use)

  No longer available

• PF-06372865 in Subjects With Photosensitive Epilepsy Start of enrollment: 2015 Dec 16

  Completed

  Phase 2

• Study of Perampanel as Adjunctive Treatment for Inadequately Controlled Seizures Associated With Lennox-Gastaut Syndrome Start of enrollment: 2016 Dec 13

  Terminated

  Phase 3

• Perampanel as Adjunctive Therapy in Pediatrics With Partial Onset Seizures or Primary Generalized Tonic Clonic Seizures Start of enrollment: 2016 Nov 16

  Completed

  Phase 3

• A Study of a Drug to be Used in Addition With Another Drug to Treat Adults With Uncontrolled Partial-onset Seizures Start of enrollment: 2017 Jul 07

  Completed

  Phase 4

• Study to Investigate Dosage, Efficacy, and Safety of Fycompa in Routine Clinical Care of Patients With Epilepsy Start of enrollment: 2017 Apr 07

  Completed

• A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization Start of enrollment: 2017 Aug 05

  Enrolling by invitation

  Phase 3

• Safety, Tolerability, and Exploratory Efficacy of Adjunctive EQU-001 for Seizures in Adults With Epilepsy Start of enrollment: 2021 Aug 31

  Active, not recruiting

  Phase 2

  Roles: Contact

• Join now to see all